Accretion Pharmaceuticals Complete Financial Statements
ACCPL • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2025 - 2024
Complete Financial Data Export
Export complete financial statements for Accretion Pharmaceuticals (ACCPL).
Downloads include all available records across all periods.
For market performance, see the
ACCPL stock price today
.
Profitability Ratios
Net Profit Margin
12.07%
2025 data
EBITDA Margin
20.69%
2025 data
Operating Margin
21.00%
2025 data
Return on Assets
17.50%
2025 data
Return on Equity
46.67%
2025 data
Balance Sheet Ratios
Current Ratio
34.00
2025 data
Debt to Equity
2.67
2025 data
Equity Ratio
37.50%
2025 data
Asset Turnover
1.45
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+48.1%
Year-over-Year
Equity Growth
+150.0%
Year-over-Year
Liabilities Growth
+48.1%
Year-over-Year
Operating Cash Flow Growth
+150.0%
Year-over-Year
Investing Cash Flow Growth
+66.7%
Year-over-Year
Financing Cash Flow Growth
-123.5%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 |
|---|---|---|---|
| Revenue | 0 | 58 | 13 |
| Expenses | 0 | 46 | 11 |
| EBITDA | 0 | 12 | 3 |
| Operating Profit Margin % | 0.00% | 21.00% | 20.00% |
| Depreciation | 0 | 1 | 0 |
| Interest | 0 | 1 | 1 |
| Profit Before Tax | 0 | 10 | 2 |
| Tax | 0 | 3 | 1 |
| Net Profit | 0 | 7 | 2 |
| Earnings Per Share (₹) | 0.00 | 8.48 | 11.08 |
Related Pages for Accretion Pharmaceuticals
Additional stock information and data for ACCPL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 |
|---|---|---|
| ASSETS | ||
| Total Assets | 40 | 27 |
| Current Assets | 34 | 22 |
| Fixed Assets | 6 | 5 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 34 | 22 |
| LIABILITIES | ||
| Total Liabilities | 40 | 27 |
| Current Liabilities | 1 | 7 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 15 | 6 |
| Share Capital | 8 | 4 |
| Reserves & Surplus | 7 | 2 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | 6 | -12 |
| Investing Activities | -2 | -6 |
| Financing Activities | -4 | 17 |
| Net Cash Flow | 0 | 0 |